Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001683168-21-001891
Filing Date
2021-05-11
Accepted
2021-05-11 16:48:19
Documents
39
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FROM 10-K TRANSITION vinings_10kt-123120.htm 10-KT 851118
2 CONSENT vinings_ex2301.htm EX-23.1 2526
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER vinings_ex3101.htm EX-31.1 8506
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER vinings_ex3102.htm EX-31.2 8357
5 CERTIFICATION vinings_ex3201.htm EX-32.1 3401
  Complete submission text file 0001683168-21-001891.txt   1928795

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ndyn-20201231.xml EX-101.INS 146779
7 XBRL SCHEMA FILE ndyn-20201231.xsd EX-101.SCH 18525
8 XBRL CALCULATION FILE ndyn-20201231_cal.xml EX-101.CAL 22948
9 XBRL DEFINITION FILE ndyn-20201231_def.xml EX-101.DEF 43663
10 XBRL LABEL FILE ndyn-20201231_lab.xml EX-101.LAB 115901
11 XBRL PRESENTATION FILE ndyn-20201231_pre.xml EX-101.PRE 98262
Mailing Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD RD, SUITE 420 WEXFORD PA 15090 724-934-6467
VININGS HOLDINGS, INC. (Filer) CIK: 0001819663 (see all company filings)

EIN.: 843998117 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-KT | Act: 34 | File No.: 000-56194 | Film No.: 21912051
SIC: 2834 Pharmaceutical Preparations